Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of California
1961
mi
from 43215
Irvine, CA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of California
1961
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Movement Disorders Center
1162
mi
from 43215
Englewood, CO
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Movement Disorders Center
1162
mi
from 43215
Englewood, CO
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
537
mi
from 43215
New Haven, CT
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of South Florida
822
mi
from 43215
Tampa, FL
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of South Florida
822
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Pacific Health Research & Education Institute
4501
mi
from 43215
Honolulu, HI
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Pacific Health Research & Education Institute
4501
mi
from 43215
Honolulu, HI
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Kentucky Medical Center
155
mi
from 43215
Lexington, KY
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Kentucky Medical Center
155
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
LSU Health Science Center
789
mi
from 43215
Shreveport, LA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
LSU Health Science Center
789
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Maryland
343
mi
from 43215
Baltimore, MD
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Maryland
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Boston University Medical Center
643
mi
from 43215
Boston, MA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Boston University Medical Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Michigan State University
205
mi
from 43215
East Lansing, MI
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Michigan State University
205
mi
from 43215
East Lansing, MI
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Struthers Parkinson's Center
630
mi
from 43215
Golden Valley, MN
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Struthers Parkinson's Center
630
mi
from 43215
Golden Valley, MN
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Nebraska Medical Center
694
mi
from 43215
Omaha, NE
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Nebraska Medical Center
694
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Nevada School of Medicine
1756
mi
from 43215
Las Vegas, NV
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Nevada School of Medicine
1756
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Atlantic Neuroscience Institute
458
mi
from 43215
Summit, NJ
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Atlantic Neuroscience Institute
458
mi
from 43215
Summit, NJ
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
515
mi
from 43215
Albany, NY
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
515
mi
from 43215
Albany, NY
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Health Quest Kingston
489
mi
from 43215
Kingston, NY
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Health Quest Kingston
489
mi
from 43215
Kingston, NY
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Weill Medical College of Cornell University
480
mi
from 43215
New York, NY
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Weill Medical College of Cornell University
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Rochester
354
mi
from 43215
Rochester, NY
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Rochester
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Ohio State University
2
mi
from 43215
Columbus, OH
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
The Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
The Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Sentara Neurology Specialists
437
mi
from 43215
Virginia Beach, VA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Sentara Neurology Specialists
437
mi
from 43215
Virginia Beach, VA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Booth Gardner Parkinson's Care Center
2000
mi
from 43215
Kirkland, WA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Booth Gardner Parkinson's Care Center
2000
mi
from 43215
Kirkland, WA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego
1926
mi
from 43215
San Diego, CA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego
1926
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
432
mi
from 43215
Atlanta, GA
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center
995
mi
from 43215
Houston, TX
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
University of Calgary
mi
from 43215
Calgary,
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
University of Calgary
mi
from 43215
Calgary,
Click here to add this to my saved trials
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Washington University
398
mi
from 43215
Saint Louis, MO
Efficacy of Isradipine in Early Parkinson Disease
Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Washington University
398
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact
Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact
Status: Enrolling
Updated:  12/31/1969
VA Portland Health Care System (VAPORHCS)
2026
mi
from 43215
Portland, OR
Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact
Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact
Status: Enrolling
Updated: 12/31/1969
VA Portland Health Care System (VAPORHCS)
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease
A Randomized Feasibility Clinical Trial of the Management of the Medically-Refractory Motor Symptoms of Advanced Idiopathic Parkinson's Disease With Unilateral Lesioning of the Subthalamic Nucleus Using the ExAblate Transcranial System
Status: Enrolling
Updated:  12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease
A Randomized Feasibility Clinical Trial of the Management of the Medically-Refractory Motor Symptoms of Advanced Idiopathic Parkinson's Disease With Unilateral Lesioning of the Subthalamic Nucleus Using the ExAblate Transcranial System
Status: Enrolling
Updated: 12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Telemedicine Intervention to Improve Cognitive Function
A Telemedicine Intervention to Improve Cognitive Function in Patients With PD
Status: Enrolling
Updated:  12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
643
mi
from 43215
Boston, MA
Telemedicine Intervention to Improve Cognitive Function
A Telemedicine Intervention to Improve Cognitive Function in Patients With PD
Status: Enrolling
Updated: 12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Exercise Targeting Cognitive Impairment in Parkinson's Disease
Exercise Targeting Cognitive Impairment in Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Exercise Targeting Cognitive Impairment in Parkinson's Disease
Exercise Targeting Cognitive Impairment in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena) (SPAN-PD™)
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
1644
mi
from 43215
Scottsdale, AZ
Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena) (SPAN-PD™)
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
1644
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials